Pfizer COVID-19 vaccine for children a while 5-11 could come by way of wintry weather, says former FDA head Dr. Scott Gottlieb

Former head of the U.S. food and Drug Administration (FDA) Dr. Scott Gottlieb talked about Monday that he expects the Pfizer vaccine could be approved for emergency use in children a long time 5 to eleven through late fall or early winter this yr.

Gottlieb, who is additionally a Pfizer board member, instructed CNBC that data from the company's vaccine trials for little ones a long time 5 to 11 "should be available in September," and then submitted to the FDA later that month.

"The application doubtless isn't going to be submitted until some element in October," said Gottlieb, who become head of the FDA from 2017 to 2019 all over the Trump administration.

"If the FDA sticks to its standard timeline, in terms of how it stories these applications, you could possibly expect that evaluate to be a four-to-six week evaluation for a doubtlessly emergency use authorization, in order that puts you on a timeline the place you're late fall, early iciness," Gottlieb introduced in a separate interview with "Squawk field."

The Pfizer vaccine is presently the only vaccine on the market to acquire full FDA approval, and even then, it has simplest received full FDA popularity of americans 16 years of age and older.

children a while 12 to 15 are nonetheless capable of get the Pfizer vaccine, but handiest beneath emergency use authorization.

the only-dose Johnson & Johnson (J&J) shot and the two-dose Moderna vaccine are additionally cleared for emergency use authorization but most effective in those 18 years of age and older.

J&J introduced in February now not too long after it received its emergency use authorization from the FDA that it would put up its Biologics License utility to the FDA for full approval in late 2021.

This potential full approval will now not turn up unless at least the conclusion of this year or early next yr.

Moderna announced in June it started a "rolling submission" to the FDA of information from its COVID-19 vaccine studies.

Moderna submitted its Biologics License software to the FDA about one month after Pfizer's submission, which means that full approval of its vaccine may be arising inside the following few weeks.

linked experiences about COVID-19:

When will the Moderna vaccine get FDA approval?

When will the Johnson & Johnson vaccine get FDA approval?

What does FDA approval imply for the COVID vaccine?

Will every person get COVID at some factor?

Our journalism wants your assist. Please subscribe nowadays to NJ.com

Katherine Rodriguez can also be reached at krodriguez@njadvancemedia.com. Have a tip? tell us at nj.com/information.

word to readers: if you are going to buy some thing through certainly one of our affiliate hyperlinks we might also earn a fee.

Post a Comment

0 Comments

COVID-19 outbreaks wreaking havoc with NFL, NBA, NHL | newest updates